GO
Loading...

The R&D elite of the market: The CNBC RQ 50

The CNBC RQ 50 is a new ranking of the most innovative companies in the market. From old-guard sectors, including industrials, oil and gas and defense to toy makers and some of Silicon Valley's elite, the R&D cultures within the RQ 50 companies prove that innovation isn't just about spending big, it's about a relentless long-term focus on R&D that optimizes return on innovation to shareholders. Read more about the RQ 50 methodology, created by Anne Marie Knott, professor of strategy at Washington University in St. Louis.

Rank
Name
2013 R&D
Expense ($M)
% of Rev.
spent on R&D
Projected Rev.
Increase ($M)*
1 McKesson 456.0 0.33% 3,801.4
2 Medicines 146.9 21.36% 18.2
3 USEC 186.1 14.23% 33.6
4 Amazon.com 6,565.0 8.82% 1,718.0
5 Silicon Laboratories 157.8 27.20% 11.7
6 Salix Pharmaceuticals 150.0 16.06% 18.7
7 Advanced Micro Devices 1,201.0 22.66% 104.9
8 SanDisk 742.3 12.03% 121.1
9 Informatica 165.9 17.49% 17.6
10 Arris Group 425.8 11.72% 66.8
11 PMC-Sierra 211.0 41.54% 9.2
12 Cubist Pharmaceuticals 513.0 48.66% 19.2
13 Synaptics 144.7 21.81% 12.0
14 NewMarket 136.6 5.99% 40.1
15 Merck & Co 7,503.0 17.04% 762.1
16 Lam Research 683.7 19.00% 59.4
17 Activision Blizzard 584.0 12.74% 75.3
18 First Solar 134.3 4.06% 54.3
19 Rovi 112.8 20.96% 8.7
20 TiVo 106.9 26.32% 6.4
21 Harmonic 99.9 21.63% 7.3
22 OshKosh 112.9 1.47% 119.6
23 Xerox 479.0 2.23% 329.8
24 Northrop Grumman 507.0 2.06% 378.7
25 Riverbed Technology 189.7 18.22% 15.8
26 Aruba Networks 139.7 23.29% 8.9
27 Intuitive Surgical 167.7 7.40% 33.7
28 F5 Networks 209.6 14.15% 22
29 Dolby Laboratories 168.7 18.55% 13.5
30 Hasbro 207.6 5.09% 58.4
31 Spansion 126.8 13.05% 13.8
32 ConocoPhillips 258.0 0.47% 771.6
33 Forest Laboratories** 788.3 21.61% 51.7
34 Ciena 383.4 18.41% 29.1
35 Xilinx 492.4 20.67% 33.2
36 Exxon Mobil 1,044.0 0.27% 5,395.8
37 Hewlett-Packard 3,135.0 2.79% 1,542.9
38 B/E Aerospace 220.9 6.34% 47.4
39 VeriFone Systems 173.3 10.15% 23.2
40 ResMed 120.1 7.93% 20.5
41 Google 7,952.0 13.29% 800.3
42 Salesforce.com 623.8 15.32% 54.2
43 Exelixis 178.8 570.44% 0.4
44 Altera 385.2 22.23% 22.7
45 Netflix 378.8 8.66% 57.1
46 Microsemi 170.6 17.48% 12.7
47 Bristol-Myers Squibb 3,731.0 22.77% 212.6
48 QLogic 147.0 31.90% 6.0
49 Dow Chemical 1,747.0 3.06% 740.1
50 Polaris Industries 139.2 3.69% 48.7

* from a 10% Increase in R&D Spending

**Forest Labs acquired by Actavis July 1, 2014

1. McKesson

2. Medicines

3. USEC

4. Amazon.com

5. Silicon Laboratories

6. Salix Pharmaceuticals

7. Advanced Micro Devices

8. SanDisk

9. Informatica

10. Arris Group

11. PMC-Sierra

12. Cubist Pharmaceuticals

13. Synaptics

14. NewMarket

15. Merck

16. Lam Research

17. Activision Blizzard

18. First Solar

19. Rovi

20. TiVo

21. Harmonic

22. Oshkosh

23. Xerox

24. Northrop Grumman

25. Riverbed Technology

26. Aruba Networks

27. Intuitive Surgical

28. F5 Networks

29. Dolby Laboratories

30. Hasbro

31. Spansion

32. ConocoPhillips

33. Forest Laboratories**

34. Ciena

35. Xilinx

36. Exxon Mobil

37. Hewlett-Packard

38. B/E Aerospace

39. VeriFone Systems

40. ResMed

41. Google

42. Salesforce.com

43. Exelixis

44. Altera

45. Netflix

46. Microsemi

47. Bristol-Myers Squibb

48. QLogic

49. Dow Chemical

50. Polaris Industries

Latest Special Reports

  • Alibaba Group headquarters in Hangzhou, China

    In-depth coverage on Alibaba's IPO, including roadshow coverage, expert analysis, and Alibaba's stock price.

  • With more than 1,600 ETFs now on the market, learn more about how advisors and investors are profiting from the ETF boom.

  • Unlock the keys to building a successful long-term financial plan: manage your money, grow your money, and protect it.

Investing